Is EL a Good Stock to Buy? The Bull and Bear Case (2026)

Last updated November 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for The Estée Lauder Companies (EL) rests on Margin recovery from the Profit Recovery and Growth Plan: Adjusted operating margin reached 15.0% in the March 2026 quarter versus 11.4% a year earlier, and adjusted gross margin expanded 140 basis points to 76.4%. The bear case rests on reported earnings are barely positive: fiscal 2026 GAAP net income was ~$182 million, or ~$0.50 a share, and the June quarter alone lost ~$116 million, so at ~213 times trailing GAAP earnings the valuation rests on adjusted and forward numbers rather than delivered GAAP profit. Analysts covering it publish targets from $70.00 to $129.00 against a $108.61 share price on November 16, 2026, so even the professionals disagree by 51% of their own average. We do not give a verdict. Each case is set out below at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

EL key stats

At $108.61 on November 16, 2026, The Estée Lauder Companies (EL) has a market cap of $39.4B, a P/E of 108.6 on trailing earnings (26.8 on forward earnings) and a dividend yield of 1.29%. It next reports earnings on February 3, 2027.

Market cap
$39.4B
P/E (trailing)
108.6
P/E (forward)
26.8
EPS (trailing 12 months)
$1.00
Price to book
9.7
Dividend yield
1.29%
Beta
1.23
Next earnings
February 3, 2027

Market cap, P/E and yield are measured at the $108.61 price on November 16, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

What's new with The Estée Lauder Companies (EL)?

The last two weeks for The Estée Lauder Companies, as of November 17, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.

  • EL closed at $108.61 on November 16, 2026, down 4.0% over the past five trading days (from $113.16).
  • The Estée Lauder Companies next reports quarterly results on February 3, 2027.
  • On November 4, 2026, The Estée Lauder Companies filed an 8-K with the SEC reporting information shared with investors (Regulation FD) (Item 7.01). Read the 8-K on sec.gov
  • On November 4, 2026, Barclays raised its target to $126.00 from $108.00 (Overweight).
  • On November 3, 2026, Citigroup raised its target to $121.00 from $115.00 (Buy).
  • On November 3, 2026, JP Morgan raised its target to $120.00 from $115.00 (Overweight).

Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

Estee Lauder sells prestige beauty across four categories: skin care (~$5.5 billion of net sales in the first nine months of fiscal 2026), makeup (~$3.3 billion), fragrance (~$2.2 billion) and hair care (~$0.4 billion). The portfolio spans roughly two dozen brands, including the namesake Estee Lauder line, La Mer, Clinique, M.A.C, Bobbi Brown, Too Faced, Smashbox, Dr.Jart+, Aveda, Origins, Le Labo, Jo Malone London, Tom Ford Beauty, Frederic Malle and The Ordinary. Distribution runs through department stores, perfumeries, specialty multi-brand retailers, freestanding stores, e-commerce, third-party marketplaces and travel retail, with the travel retail business reported inside the Asia/Pacific region. Geographically the company is split between the Americas (~$3.5 billion in the nine months), Europe, the UK, Ireland and emerging markets (~$2.9 billion), Asia/Pacific (~$2.8 billion) and Mainland China (~$2.2 billion), which makes China and Asian travel retail unusually important to results. The investment picture is a repair job in progress. Fiscal 2025 net sales fell ~8% to ~$14.3 billion and the company posted a net loss of ~$1.1 billion after ~$861 million of goodwill and intangible impairments plus talc settlement charges. Through the first nine months of fiscal 2026 net sales rose ~5% as reported to ~$11.4 billion, operating income swung to ~$819 million from a ~$395 million loss, and management raised full-year guidance (in spring 2026) to ~3% organic sales growth with adjusted operating margin of 10.7% to 11.0% and adjusted diluted EPS of $2.35 to $2.45. Reported profitability still lags because the Profit Recovery and Growth Plan restructuring is running at ~$1.5 billion to ~$1.7 billion of pre-tax charges and 9,000 to 10,000 net position reductions, tariffs are expected to cost ~$100 million of fiscal 2026 profit, and an $84 million net charge for a securities class action settlement landed in the March quarter. Fiscal 2026 closed better than that guidance. Full-year net sales rose ~5% to ~$15.05 billion, and adjusted diluted EPS across the four quarters summed to ~$2.51, above the $2.35 to $2.45 range, after the June quarter delivered ~$0.39 against a ~$0.32 consensus on ~$3.63 billion of sales. The company beat EPS estimates in all four quarters of the year. GAAP results were still thin: the June quarter posted a ~$116 million net loss and the full year a ~$182 million net profit, a 1.2% net margin, against a ~$1.13 billion loss in fiscal 2025. The stock has responded. As of October 16, 2026 EL closed near ~$106.68, roughly flat for calendar 2026 (down ~0.1%) but up ~29.5% over three months and ~10.2% over one year, after a 52-week range of ~$66.22 to ~$121.64. Barclays upgraded the shares to Overweight on October 5, 2026, and Goldman Sachs and Morgan Stanley raised targets to $124 and $112 in mid-October, while UBS trimmed to $104 with a Neutral rating. Fiscal first-quarter 2027 results are scheduled for November 2, 2026, with consensus EPS near ~$0.50 on ~$3.65 billion of sales.

The bull case: what would have to be true for $129.00

The most optimistic published target on EL is $129.00, +18.8% from the $108.61 share price on November 16, 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. Margin recovery from the Profit Recovery and Growth Plan

Adjusted operating margin reached 15.0% in the March 2026 quarter versus 11.4% a year earlier, and adjusted gross margin expanded 140 basis points to 76.4%. Management attributes most of that to PRGP savings landing faster than planned, funded partly by cutting non-consumer-facing costs. Company guidance calls for adjusted operating margin of 10.7% to 11.0% in fiscal 2026 and a preliminary 12.5% to 13.0% in fiscal 2027, which would be the first sustained margin rebuild in four years. The June 2026 quarter kept the trend going, with adjusted EPS of ~$0.39 against a ~$0.32 estimate, and full fiscal 2026 adjusted EPS of ~$2.51 landed above the guided range. Analysts now expect ~$3.32 for fiscal 2027 and ~$3.93 for fiscal 2028.

2. China and Asian travel retail stabilising

Mainland China net sales grew to ~$774 million in the March quarter from ~$696 million, and Mainland China operating income more than doubled to ~$159 million, with the company saying it gained prestige beauty share. Asian travel retail remains a swing factor and is still absorbing a transitory headwind from the change of duty-free operators at the Beijing and Shanghai airports. Because travel retail sits inside the Asia/Pacific region, recovery there flows straight into the segment that carries the group's highest reported margin.

3. Fragrance as the growth engine

Fragrance net sales rose to ~$2.16 billion in the first nine months of fiscal 2026 from ~$1.93 billion, growing double digits organically, and swung to ~$212 million of category operating income from a ~$354 million loss. Le Labo, Jo Malone London, Tom Ford Beauty and Frederic Malle sit in a premium niche segment that has held pricing power while makeup has been competitive. Skin care remains the largest and most profitable category at ~$5.49 billion of sales and ~$1.09 billion of category operating income.

4. Beauty Reimagined and the One ELC operating model

The current strategic frame, introduced after the fiscal 2025 leadership change to Stephane de La Faverie, prioritises faster innovation cycles, broader consumer coverage and reallocating savings into consumer-facing spend. Management describes the One Operating Ecosystem as fully deployed during fiscal 2027. Preliminary fiscal 2027 guidance of 3% to 5% net sales growth is the first multi-year growth framework the company has offered since the travel retail downturn began. Consensus for fiscal 2027 sits at ~$15.73 billion of revenue, roughly 4.5% above fiscal 2026, which is inside that preliminary range.

The bear case: what would have to be true for $70.00

The most pessimistic published target is $70.00, -35.5% from the current price. It is neither a floor nor a forecast; it is roughly what one analyst thinks The Estée Lauder Companies is worth if the risks below bite instead of the drivers above.

Reported earnings are barely positive: fiscal 2026 GAAP net income was ~$182 million, or ~$0.50 a share, and the June quarter alone lost ~$116 million, so at ~213 times trailing GAAP earnings the valuation rests on adjusted and forward numbers rather than delivered GAAP profit. Leverage is meaningful at ~$9.25 billion of total debt against ~$3.5 billion of cash, roughly ~$5.75 billion net, while the Class A buyback has been suspended since December 2022 and the dividend was cut to $0.35 per quarter. A securities class action in the Southern District of New York (In re The Estee Lauder Companies, Inc. Securities Litigation, No. 1:23-cv-10669, S.D.N.Y.) over travel retail and daigou disclosures survived a motion to dismiss in March 2025 and reached an agreement in principle to settle for $210 million on April 2, 2026, with preliminary approval granted May 13, 2026 and a final approval hearing scheduled for August 20, 2026; several shareholder derivative suits over the same conduct remain outstanding in New York and Delaware, and cosmetic talcum powder asbestos claims are being resolved under settlement frameworks running through 2029. Tariffs are expected to reduce fiscal 2026 profitability by ~$100 million, and because tariff costs are capitalised in inventory for roughly six months, later rate reductions do not help the current year. Middle East disruption, which touched ~2% of fiscal 2025 net sales, was flagged as a larger drag on the June 2026 quarter than on the March quarter. After a ~30% three-month rally the stock has also priced in a good part of the recovery, which raises the bar for the November 2, 2026 report.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding EL already, these risks exist either way; what to check is whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on EL

28 analysts cover EL, with an average target of $114.89 (+5.8% against $108.61) and a split of 15 buy, 14 hold, 1 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the EL forecast and price target page.

How is EL valued?

Market cap, P/E and dividend yield at today's price are in the EL key stats above. The business figures below come from The Estée Lauder Companies's reported results as of October 2026 and change when it next reports.

  • Revenue (FY2026, ended June 30): ~$15.05 billion, up ~5%
  • Net income (FY2026): ~$182 million GAAP, EPS ~$0.50; adjusted EPS ~$2.51
  • Gross / operating margin (TTM): ~75.5% gross, ~7.0% operating
  • Fiscal 2027 consensus: ~$15.73 billion revenue, ~$3.32 adjusted EPS
  • Dividend: $0.35 per quarter, ~$1.40 annualised, ~1.3% yield; buyback suspended since December 2022
  • Free cash flow (TTM): ~$1.81 billion

As of October 2026: At ~$107, EL trades near ~32 times fiscal 2027 consensus adjusted EPS of ~$3.32 and ~27 times the fiscal 2028 estimate of ~$3.93; the trailing GAAP multiple above 200x is not meaningful because restructuring and settlement charges sit between gross and net profit. The gap between a ~75.5% gross margin and a ~7.0% operating margin is where the whole debate sits, and the multiple reflects an assumption that most of those charges do not repeat. Free cash flow of ~$1.81 billion over the trailing year is the strongest sign the repair is real.

How do you decide if EL is a buy?

Whether EL is a buy is easier to judge through four narrower questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold EL indirectly through an index or sector ETF before adding more.

What would change your mind on EL

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: Margin recovery from the Profit Recovery and Growth Plan stalls in the reported numbers. A shift in the narrative around them is not enough on its own.
  • Bear case breaks if: reported earnings are barely positive: fiscal 2026 GAAP net income was ~$182 million, or ~$0.50 a share, and the June quarter alone lost ~$116 million, so at ~213 times trailing GAAP earnings the valuation rests on adjusted and forward numbers rather than delivered GAAP profit fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the EL stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about EL against your real portfolio and see your actual exposure before deciding.

Your questions about The Estée Lauder Companies

Ask Walnut's AI anything about EL and see how it fits what you own.

FAQ

Is EL a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on Margin recovery from the Profit Recovery and Growth Plan, with revenue (fy2026, ended june 30) at ~$15.05 billion, up ~5%. The bear case rests on reported earnings are barely positive: fiscal 2026 GAAP net income was ~$182 million, or ~$0.50 a share, and the June quarter alone lost ~$116 million, so at ~213 times trailing GAAP earnings the valuation rests on adjusted and forward numbers rather than delivered GAAP profit. Analysts covering it are spread from $70.00 to $129.00, a spread wide enough to show the question is contested. If you believe the thesis, the questions that matter next are sizing and overlap; timing comes after. Walnut is not an investment adviser and this is not a recommendation.

Should I sell EL?

+

Nobody can answer that for you, and a more useful version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Reported earnings are barely positive: fiscal 2026 GAAP net income was ~$182 million, or ~$0.50 a share, and the June quarter alone lost ~$116 million, so at ~213 times trailing GAAP earnings the valuation rests on adjusted and forward numbers rather than delivered GAAP profit. If that risk is what you were worried about and it is now playing out, take it seriously. If the price simply fell while the thesis held, the situation is different. The most pessimistic published target is $70.00, -35.5% from the $108.61 price, which is one analyst's downside case. It is not a floor. Walnut is not an investment adviser.

What is the bull case for EL?

+

Margin recovery from the Profit Recovery and Growth Plan. Adjusted operating margin reached 15.0% in the March 2026 quarter versus 11.4% a year earlier, and adjusted gross margin expanded 140 basis points to 76.4%. The most optimistic analyst target on EL is $129.00, +18.8% from the $108.61 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for EL?

+

Reported earnings are barely positive: fiscal 2026 GAAP net income was ~$182 million, or ~$0.50 a share, and the June quarter alone lost ~$116 million, so at ~213 times trailing GAAP earnings the valuation rests on adjusted and forward numbers rather than delivered GAAP profit. Leverage is meaningful at ~$9.25 billion of total debt against ~$3.5 billion of cash, roughly ~$5.75 billion net, while the Class A buyback has been suspended since December 2022 and the dividend was cut to $0.35 per quarter. A securities class action in the Southern District of New York (In re The Estee Lauder Companies, Inc. Securities Litigation, No. 1:23-cv-10669, S.D.N.Y.) over travel retail and daigou disclosures survived a motion to dismiss in March 2025 and reached an agreement in principle to settle for $210 million on April 2, 2026, with preliminary approval granted May 13, 2026 and a final approval hearing scheduled for August 20, 2026; several shareholder derivative suits over the same conduct remain outstanding in New York and Delaware, and cosmetic talcum powder asbestos claims are being resolved under settlement frameworks running through 2029. Tariffs are expected to reduce fiscal 2026 profitability by ~$100 million, and because tariff costs are capitalised in inventory for roughly six months, later rate reductions do not help the current year. Middle East disruption, which touched ~2% of fiscal 2025 net sales, was flagged as a larger drag on the June 2026 quarter than on the March quarter. After a ~30% three-month rally the stock has also priced in a good part of the recovery, which raises the bar for the November 2, 2026 report. The most pessimistic published target is $70.00, -35.5% from the current price, which is roughly what one analyst thinks the stock is worth if these risks bite and the drivers do not.

What does The Estée Lauder Companies do?

+

The Estee Lauder Companies is the prestige beauty group behind La Mer, Clinique, M.A.C and Jo Malone London, with roughly $14.8 billion in trailing net sales.

What would have to change for EL to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Margin recovery from the Profit Recovery and Growth Plan) stalling in the reported numbers (a change in the narrative alone does not count), the risk above (reported earnings are barely positive: fiscal 2026 GAAP net income was ~$182 million, or ~$0.50 a share, and the June quarter alone lost ~$116 million, so at ~213 times trailing GAAP earnings the valuation rests on adjusted and forward numbers rather than delivered GAAP profit) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What does Estee Lauder actually sell?

+

Prestige beauty in four categories: skin care, makeup, fragrance and hair care. Skin care is the largest at ~$5.5 billion of net sales in the first nine months of fiscal 2026, ahead of makeup at ~$3.3 billion and fragrance at ~$2.2 billion. Roughly two dozen brands sit under the group, including La Mer, Clinique, M.A.C, Jo Malone London, Tom Ford Beauty and The Ordinary.

Does Estee Lauder have a dual-class share structure?

+

Yes. Class A shares trade on the NYSE under EL and carry one vote each. Class B shares, held largely by members of the Lauder family, carry ten votes each and are not publicly traded. With ~114.5 million Class B shares outstanding at March 31, 2026 against ~247 million Class A shares outstanding, the Class B block alone represents roughly ~82% of total voting power, so public shareholders have economic exposure with limited voting influence.

Why is Estee Lauder unprofitable on a GAAP basis?

+

It has only just stopped being unprofitable. Fiscal 2026 GAAP net income was ~$182 million, or ~$0.50 a share, after a ~$1.13 billion loss in fiscal 2025, and the June 2026 quarter on its own still lost ~$116 million. Fiscal 2025 carried ~$861 million of goodwill and intangible impairments plus ~$159 million of talc settlement charges, and fiscal 2026 absorbed ~$520 million of restructuring charges in nine months plus an $84 million net securities settlement charge. Adjusted EPS for fiscal 2026 was ~$2.51, which is the number management points to.

Walnut is informational, not investment advice, and gives no verdict on EL. Analyst targets referenced here come from a November 2026 pull of published third-party research and change constantly. The share price is the last one Yahoo Finance reported on November 16, 2026. Verify current figures with your broker before acting on them.

The case for and against similar stocks